Justices Halt Ax Of Sanofi's Insulin Patents Over Arthrex
Sanofi-Aventis can push back a Federal Circuit ruling that struck down its patents on the insulin medication Lantus until later this week, the U.S. Supreme Court has ruled, giving Mylan time...To view the full article, register now.
Already a subscriber? Click here to view full article